FOXL2 Impairment in Human Disease

Publisher： Karger

E-ISSN： 1663-2826|77|1|2-11

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.77, Iss.1, 2012-01, pp. : 2-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Depression and Cognitive Impairment in Parkinson's Disease: A Role for Inflammation and Immunomodulation?

By  

Neuroimmunomodulation, Vol. 21, Iss. 2-3, 2014-02 ,pp. : 88-94

Karger

Access to resources Recommend Favorite

Plasma Aminothiol Compounds, but Not Serum Tumor Necrosis Factor Receptor II and Soluble Receptor for Advanced Glycation End Products, Are Related to the Cognitive Impairment in Alzheimer’s Disease and Mild Cognitive Impairment Patients

By  

Neuroimmunomodulation, Vol. 14, Iss. 3-4, 2007-12 ,pp. : 163-167

Karger

Access to resources Recommend Favorite

Immunoendocrine Alterations during Human Tuberculosis as an Integrated View of Disease Pathology

By  

Neuroimmunomodulation, Vol. 16, Iss. 2, 2009-02 ,pp. : 68-77

Karger

Access to resources Recommend Favorite

Spectrum of Human Foxe1/TTF2 Mutations

By  

Hormone Research in Paediatrics, Vol. 73, Iss. 6, 2010-05 ,pp. : 423-429

Karger

Access to resources Recommend Favorite

Mechanisms of Steroid Impairment of Growth

By  

Hormone Research in Paediatrics, Vol. 58, Iss. 1, 2004-11 ,pp. : 33-38

Karger

Access to resources Recommend Favorite